Balance Sheet Alcon Inc.

Equities

ALC

CH0432492467

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe Other stock markets 03:26:24 2025-12-16 am EST			5-day change	1st Jan Change
63.21 ^CHF	-0.05%		-1.75%	-18.02%

Dec. 12	Glass Lewis Reaffirms its Recommendations to Shareholders of STAAR	CI
Dec. 11	Stocks Extend Losing Streak as Swiss National Bank Holds Key Rate at Zero	MT

47631f80e.CBnCcjifQXChOZ1-Gdn8mIOtL4zqrf6VlWuE4x4mqBo.aWGWPXP6Oz7NT9dIaYCp8O7AHf2slbzyoxO9vCdK20JBTocbYcowA85x0A

Published financial data: ALCON INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	6.76B	8.22B	8.65B	9.37B	9.84B
Other Revenues, Total	70M	69M	63M	85M	75M
Total Revenues	6.83B	8.29B	8.72B	9.46B	9.91B
Cost of Goods Sold, Total	3.78B	3.6B	3.91B	4.21B	4.4B
Gross Profit	3.06B	4.7B	4.81B	5.25B	5.52B
Selling General & Admin Expenses, Total	2.67B	3.06B	3.07B	3.21B	3.25B
R&D Expenses	672M	703M	723M	845M	867M
Other Operating Expenses	-22M	35M	196M	132M	30M
Other Operating Expenses, Total	3.32B	3.8B	3.99B	4.19B	4.15B
Operating Income	-266M	901M	820M	1.06B	1.37B
Interest Expense, Total	-124M	-120M	-134M	-189M	-192M
Interest And Investment Income	6M	3M	16M	45M	43M
Net Interest Expenses	-118M	-117M	-118M	-144M	-149M
Income (Loss) On Equity Invest.	-	-	-	-	-8M
Currency Exchange Gains (Loss)	-22M	-29M	-58M	-39M	-50M
Other Non Operating Income (Expenses)	-9M	-10M	-12M	-11M	50M
EBT, Excl. Unusual Items	-415M	745M	632M	867M	1.21B
Restructuring Charges	-49M	-68M	-	-39M	1M
Merger & Related Restructuring Charges	-	-	-20M	-	-4M
Gain (Loss) On Sale Of Assets	-	-	-	-	57M
Asset Writedown	-167M	-225M	-61M	-	-9M
Legal Settlements	-	-50M	-90M	-	-
Other Unusual Items	-4M	16M	2M	4M	-
EBT, Incl. Unusual Items	-635M	418M	463M	832M	1.26B
Income Tax Expense	-104M	42M	128M	-142M	238M
Earnings From Continuing Operations	-531M	376M	335M	974M	1.02B
Net Income to Company	-531M	376M	335M	974M	1.02B
Net Income - (IS)	-531M	376M	335M	974M	1.02B
Net Income to Common Incl Extra Items	-531M	376M	335M	974M	1.02B
Net Income to Common Excl. Extra Items	-531M	376M	335M	974M	1.02B
Per Share Items
Net EPS - Basic	-1.09	0.77	0.68	1.98	2.06
Basic EPS - Continuing Operations	-1.09	0.77	0.68	1.98	2.06
Basic Weighted Average Shares Outstanding	489M	490M	491M	493M	494M
Net EPS - Diluted	-1.09	0.76	0.68	1.96	2.05
Diluted EPS - Continuing Operations	-1.09	0.76	0.68	1.96	2.05
Diluted Weighted Average Shares Outstanding	489M	493M	494M	496M	498M
Normalized Basic EPS	-0.53	0.95	0.8	1.1	1.53
Normalized Diluted EPS	-0.53	0.94	0.8	1.09	1.52
Dividend Per Share	0.11	0.22	0.23	0.29	0.31
Payout Ratio	-	14.36	29.85	11.91	12.77
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	1.27B	2.04B	1.87B	2.19B	2.5B
EBITA	979M	1.72B	1.54B	1.81B	2.11B
EBIT	-266M	901M	820M	1.06B	1.37B
EBITDAR	1.27B	2.04B	1.87B	2.19B	2.5B
Total Revenues (As Reported)	6.83B	8.29B	8.72B	9.46B	9.91B
Effective Tax Rate - (Ratio)	16.38	10.05	27.65	-17.07	18.95
Current Domestic Taxes	14M	118M	17M	74M	95M
Current Foreign Taxes	105M	116M	146M	93M	239M
Total Current Taxes	119M	234M	163M	167M	334M
Deferred Domestic Taxes	-96M	-45M	-53M	-313M	-25M
Deferred Foreign Taxes	-127M	-147M	18M	4M	-71M
Total Deferred Taxes	-223M	-192M	-35M	-309M	-96M
Normalized Net Income	-259M	466M	395M	542M	757M
Interest on Long-Term Debt	30M	25M	29M	27M	27M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	1.18B	881M	742M	859M	908M
Net Rental Expense, Total	4M	7M	3M	3M	3M
Imputed Operating Lease Interest Expense	953K	1.5M	673K	887K	896K
Imputed Operating Lease Depreciation	3.05M	5.5M	2.33M	2.11M	2.1M
Stock-Based Comp., Other (Total)	113M	151M	152M	159M	150M
Total Stock-Based Compensation	113M	151M	152M	159M	150M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.56B	1.58B	980M	1.09B	1.68B
Short Term Investments	-	3M	-	7M	165M
Trading Asset Securities, Total	12M	-	-	-	-
Total Cash And Short Term Investments	1.57B	1.58B	980M	1.1B	1.84B
Accounts Receivable, Total	1.47B	1.59B	1.78B	1.89B	1.85B
Other Receivables	181M	193M	189M	197M	199M
Total Receivables	1.65B	1.79B	1.96B	2.08B	2.05B
Inventory	1.64B	1.9B	2.11B	2.32B	2.27B
Prepaid Expenses	93M	92M	107M	112M	1M
Other Current Assets, Total	32M	31M	33M	29M	147M
Total Current Assets	4.99B	5.39B	5.19B	5.65B	6.31B
Gross Property Plant And Equipment	6.28B	6.73B	7.17B	7.7B	8.04B
Accumulated Depreciation	-2.49B	-2.65B	-2.75B	-2.98B	-3.2B
Net Property Plant And Equipment	3.78B	4.08B	4.42B	4.72B	4.84B
Long-term Investments	40M	52M	108M	148M	283M
Goodwill	8.9B	8.9B	8.97B	8.93B	8.95B
Other Intangibles, Total	8.37B	8.21B	9.69B	9.06B	8.59B
Accounts Receivable Long-Term	117M	110M	119M	126M	121M
Loans Receivable Long-Term	22M	20M	22M	205M	220M
Deferred Tax Assets Long-Term	399M	409M	411M	443M	421M
Deferred Charges Long-Term	727M	557M	-	-	-
Other Long-Term Assets, Total	250M	269M	281M	336M	622M
Total Assets	27.6B	28B	29.21B	29.61B	30.35B
Liabilities
Accounts Payable, Total	876M	903M	861M	811M	773M
Accrued Expenses, Total	562M	701M	713M	763M	709M
Short-term Borrowings	61M	23M	28M	53M	75M
Current Portion of Long-Term Debt	108M	91M	79M	92M	30M
Current Portion of Leases	70M	67M	71M	71M	68M
Current Income Taxes Payable	149M	187M	219M	114M	104M
Unearned Revenue Current, Total	110M	108M	89M	78M	73M
Other Current Liabilities	322M	392M	722M	498M	446M
Total Current Liabilities	2.26B	2.47B	2.78B	2.48B	2.28B
Long-Term Debt	3.95B	3.97B	4.54B	4.59B	4.54B
Long-Term Leases	315M	339M	359M	335M	429M
Pension & Other Post Retirement Benefits	671M	595M	396M	434M	406M
Deferred Tax Liability Non Current	1.2B	1.03B	1.06B	797M	810M
Other Non Current Liabilities	389M	345M	390M	350M	333M
Total Liabilities	8.78B	8.74B	9.53B	8.99B	8.79B
Common Stock, Total	20M	20M	20M	20M	20M
Retained Earnings	-	-	-	-	-
Comprehensive Income and Other	18.8B	19.24B	19.66B	20.6B	21.53B
Total Common Equity	18.82B	19.26B	19.68B	20.62B	21.55B
Total Equity	18.82B	19.26B	19.68B	20.62B	21.55B
Total Liabilities And Equity	27.6B	28B	29.21B	29.61B	30.35B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	489M	490M	490M	493M	495M
ECS Total Common Shares Outstanding	489M	490M	490M	493M	495M
Book Value / Share	38.47	39.29	40.15	41.81	43.58
Tangible Book Value	1.55B	2.14B	1.02B	2.64B	4.02B
Tangible Book Value Per Share	3.16	4.37	2.08	5.35	8.13
Total Debt	4.5B	4.49B	5.08B	5.14B	5.14B
Net Debt	2.93B	2.91B	4.1B	4.04B	3.3B
Debt Equivalent of Unfunded Proj. Benefit Obligation	298M	250M	146M	190M	162M
Debt Equivalent Oper. Leases	32M	56M	24M	24M	24M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	278M	336M	433M	434M	438M
Inventories - Work In Process, Total	136M	169M	201M	197M	199M
Inventories - Finished Goods, Total	1.23B	1.39B	1.48B	1.69B	1.63B
Land - (BS)	35M	36M	35M	38M	39M
Buildings, Total	1.88B	1.99B	2.09B	2.29B	2.34B
Machinery, Total	3.42B	3.55B	3.69B	3.99B	4.27B
Full Time Employees	23.66K	24.39K	25.18K	25.32K	25.6K
Accumulated Allowance for Doubtful Accounts (Supple)	68M	55M	57M	44M	41M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-531M	376M	335M	974M	1.02B
Depreciation & Amortization - CF	370M	402M	410M	474M	473M
Amortization of Goodwill and Intangible Assets - (CF)	1.24B	815M	715M	745M	743M
Depreciation & Amortization, Total	1.62B	1.22B	1.12B	1.22B	1.22B
(Gain) Loss From Sale Of Asset	42M	13M	10M	27M	16M
(Gain) Loss on Sale of Investments - (CF)	5M	3M	-14M	7M	-
Asset Writedown & Restructuring Costs	6M	-	-	-	10M
(Income) Loss On Equity Investments - (CF)	-	-	-	-	8M
Stock-Based Compensation (CF)	105M	138M	140M	144M	150M
Other Operating Activities, Total	-259M	-26M	242M	-319M	-65M
Change In Accounts Receivable	43M	-198M	-164M	-110M	-55M
Change In Inventories	-159M	-326M	-217M	-271M	-47M
Change In Accounts Payable	-21M	60M	-48M	-51M	-15M
Change in Other Net Operating Assets	-23M	88M	-192M	-232M	-159M
Cash from Operations	823M	1.34B	1.22B	1.39B	2.08B
Capital Expenditure	-479M	-700M	-1.12B	-660M	-473M
Sale of Property, Plant, and Equipment	6M	-	-	-	-
Cash Acquisitions	-	-	-666M	-	-61M
Sale (Purchase) of Intangible assets	-88M	-480M	-109M	-193M	-197M
Investment in Marketable and Equity Securities, Total	-11M	-18M	31M	-241M	-428M
Other Investing Activities, Total	-	-	-	-	-8M
Cash from Investing	-572M	-1.2B	-1.86B	-1.09B	-1.17B
Short Term Debt Issued, Total	-	-	771M	77M	-
Long-Term Debt Issued, Total	744M	52M	1.82B	29M	59M
Total Debt Issued	744M	52M	2.59B	106M	59M
Short Term Debt Repaid, Total	-139M	-43M	-1.13B	-	-
Long-Term Debt Repaid, Total	-69M	-72M	-1.24B	-113M	-196M
Total Debt Repaid	-208M	-115M	-2.38B	-113M	-196M
Repurchase of Common Stock	-	-	-50M	-49M	-47M
Common Dividends Paid	-	-54M	-100M	-116M	-130M
Common & Preferred Stock Dividends Paid	-	-54M	-100M	-116M	-130M
Other Financing Activities, Total	-70M	-6M	-66M	-39M	-8M
Cash from Financing	466M	-123M	-8M	-211M	-322M
Foreign Exchange Rate Adjustments	18M	-6M	61M	31M	-6M
Net Change in Cash	735M	18M	-595M	114M	582M
Supplemental Items
Cash Interest Paid	105M	108M	111M	176M	182M
Cash Income Tax Paid (Refund)	97M	175M	178M	255M	326M
Levered Free Cash Flow	921M	558M	384M	441M	1.35B
Unlevered Free Cash Flow	999M	633M	468M	559M	1.47B
Change In Net Working Capital	-4M	118M	92M	629M	81M
Net Debt Issued / Repaid	536M	-63M	208M	-7M	-137M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-0.6	2.03	1.79	2.26	2.85
Return on Total Capital	-0.72	2.39	2.11	2.62	3.26
Return On Equity %	-2.79	1.97	1.72	4.83	4.83
Return on Common Equity	-2.79	1.97	1.72	4.83	4.83
Margin Analysis
Gross Profit Margin %	44.72	56.64	55.15	55.49	55.65
SG&A Margin	39.1	36.87	35.2	33.94	32.79
EBITDA Margin %	18.59	24.57	21.44	23.15	25.23
EBITA Margin %	14.33	20.7	17.61	19.1	21.3
EBIT Margin %	-3.89	10.87	9.41	11.22	13.8
Income From Continuing Operations Margin %	-7.77	4.54	3.84	10.3	10.27
Net Income Margin %	-7.77	4.54	3.84	10.3	10.27
Net Avail. For Common Margin %	-7.77	4.54	3.84	10.3	10.27
Normalized Net Income Margin	-3.8	5.62	4.53	5.73	7.64
Levered Free Cash Flow Margin	13.48	6.73	4.4	4.66	13.62
Unlevered Free Cash Flow Margin	14.62	7.64	5.36	5.91	14.83
Asset Turnover
Asset Turnover	0.25	0.3	0.3	0.32	0.33
Fixed Assets Turnover	1.89	2.11	2.05	2.07	2.07
Receivables Turnover (Average Receivables)	4.54	5.37	5.14	5.12	5.26
Inventory Turnover (Average Inventory)	2.4	2.03	1.95	1.9	1.92
Short Term Liquidity
Current Ratio	2.21	2.18	1.87	2.28	2.77
Quick Ratio	1.43	1.36	1.06	1.28	1.71
Operating Cash Flow to Current Liabilities	0.36	0.54	0.44	0.56	0.91
Days Sales Outstanding (Average Receivables)	80.64	67.94	71.03	71.31	69.56
Days Outstanding Inventory (Average Inventory)	152.57	179.86	187.07	192.17	191.08
Average Days Payable Outstanding	79.86	84.33	78.14	69.02	66.76
Cash Conversion Cycle (Average Days)	153.34	163.47	179.96	194.46	193.88
Long Term Solvency
Total Debt/Equity	23.92	23.3	25.81	24.95	23.85
Total Debt / Total Capital	19.31	18.89	20.51	19.97	19.26
LT Debt/Equity	22.65	22.36	24.9	23.9	23.05
Long-Term Debt / Total Capital	18.28	18.13	19.79	19.13	18.61
Total Liabilities / Total Assets	31.8	31.23	32.63	30.36	28.98
EBIT / Interest Expense	-2.15	7.51	6.12	5.61	7.12
EBITDA / Interest Expense	10.88	17.65	14.51	12.06	13.46
(EBITDA - Capex) / Interest Expense	7.02	11.82	6.15	8.57	10.99
Total Debt / EBITDA	3.34	2.12	2.61	2.26	1.99
Net Debt / EBITDA	2.17	1.37	2.11	1.77	1.28
Total Debt / (EBITDA - Capex)	5.18	3.16	6.16	3.18	2.43
Net Debt / (EBITDA - Capex)	3.37	2.05	4.97	2.5	1.56
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-8.99	21.34	5.14	8.47	4.82
Gross Profit, 1 Yr. Growth %	-16.41	53.66	2.36	9.15	4.97
EBITDA, 1 Yr. Growth %	-12.17	60.39	-3.31	12.84	13.01
EBITA, 1 Yr. Growth %	-16.96	75.28	-4.78	12.45	15.36
EBIT, 1 Yr. Growth %	-380	-438.72	2.89	19.08	26.08
Earnings From Cont. Operations, 1 Yr. Growth %	-19.05	-170.81	-10.9	190.75	4.52
Net Income, 1 Yr. Growth %	-19.05	-170.81	-10.9	190.75	4.52
Normalized Net Income, 1 Yr. Growth %	843.18	-279.52	-1.4	23.33	35.91
Diluted EPS Before Extra, 1 Yr. Growth %	-18.88	-169.72	-10.53	188.24	4.59
Accounts Receivable, 1 Yr. Growth %	-2.91	8.51	11.42	6.25	-1.75
Inventory, 1 Yr. Growth %	9.24	15.51	11.06	10.1	-2.33
Net Property, Plant and Equip., 1 Yr. Growth %	10.07	7.93	8.16	6.95	2.43
Total Assets, 1 Yr. Growth %	-0.2	1.45	4.32	1.54	2.48
Tangible Book Value, 1 Yr. Growth %	73.43	38.53	-35.81	148.4	52.39
Common Equity, 1 Yr. Growth %	-2.49	2.31	2.19	4.81	4.5
Cash From Operations, 1 Yr. Growth %	-10.54	63.43	-9.52	14.05	49.64
Capital Expenditures, 1 Yr. Growth %	-13.38	46.14	60.14	-41.12	-28.33
Levered Free Cash Flow, 1 Yr. Growth %	14.76	-39.42	-22.18	14.81	206.12
Unlevered Free Cash Flow, 1 Yr. Growth %	14.36	-36.61	-17.71	19.5	162.91
Dividend Per Share, 1 Yr. Growth %	-	94.11	3.52	25.5	8.41
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-2.26	5.09	12.95	6.79	6.63
Gross Profit, 2 Yr. CAGR %	-7.45	13.33	25.36	5.7	7.09
EBITDA, 2 Yr. CAGR %	-15.03	18.69	35.17	5.84	14.7
EBITA, 2 Yr. CAGR %	-19.69	20.64	45.41	5.16	15.99
EBIT, 2 Yr. CAGR %	48.27	207.96	25.7	13.89	22.21
Earnings From Cont. Operations, 2 Yr. CAGR %	52.94	-24.29	-20.57	60.95	74.32
Net Income, 2 Yr. CAGR %	52.94	-24.29	-20.57	60.95	74.32
Normalized Net Income, 2 Yr. CAGR %	143.49	311.48	-2.73	14.44	30.88
Diluted EPS Before Extra, 2 Yr. CAGR %	53.11	-24.79	-21.02	60.59	73.63
Accounts Receivable, 2 Yr. CAGR %	2.18	2.64	9.96	8.81	2.17
Inventory, 2 Yr. CAGR %	6.85	12.33	13.26	10.58	3.7
Net Property, Plant and Equip., 2 Yr. CAGR %	14.63	8.99	8.04	7.55	4.67
Total Assets, 2 Yr. CAGR %	0.99	0.62	2.87	2.84	2.01
Tangible Book Value, 2 Yr. CAGR %	-31.6	55	-18.88	28.97	94.56
Common Equity, 2 Yr. CAGR %	-8.82	-0.12	2.25	3.49	4.66
Cash From Operations, 2 Yr. CAGR %	-15.03	20.91	21.6	1.59	30.64
Capital Expenditures, 2 Yr. CAGR %	-4.39	12.51	52.98	-2.9	-35.04
Levered Free Cash Flow, 2 Yr. CAGR %	-11.1	-16.62	-29.36	-6.67	104.2
Unlevered Free Cash Flow, 2 Yr. CAGR %	-8.02	-14.86	-25.69	-1.92	89.93
Dividend Per Share, 2 Yr. CAGR %	-	-	41.75	13.98	16.64
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	0.2	5.04	5.1	11.43	6.13
Gross Profit, 3 Yr. CAGR %	-1.56	9.59	9.55	19.7	5.5
EBITDA, 3 Yr. CAGR %	-2.21	5.01	8.93	28.86	8.58
EBITA, 3 Yr. CAGR %	-5.03	4.17	9.19	35.5	8.94
EBIT, 3 Yr. CAGR %	71.21	95.27	105.13	26.92	18.7
Earnings From Cont. Operations, 3 Yr. CAGR %	27.53	18.32	-20.07	22.41	39.38
Net Income, 3 Yr. CAGR %	27.53	18.32	-20.07	22.41	39.38
Normalized Net Income, 3 Yr. CAGR %	417.18	119.96	143.08	9.08	22.3
Diluted EPS Before Extra, 3 Yr. CAGR %	27.98	17.8	-20.31	21.6	39.2
Accounts Receivable, 3 Yr. CAGR %	-1.11	4.25	5.49	8.71	5.17
Inventory, 3 Yr. CAGR %	8.06	9.66	11.9	12.2	6.1
Net Property, Plant and Equip., 3 Yr. CAGR %	13.9	12.35	8.71	7.68	5.82
Total Assets, 3 Yr. CAGR %	0.26	1.14	1.84	2.38	2.72
Tangible Book Value, 3 Yr. CAGR %	-17.72	-13.46	4.5	19.47	36.35
Common Equity, 3 Yr. CAGR %	-6.5	-5.25	0.64	3.09	3.83
Cash From Operations, 3 Yr. CAGR %	-12.25	5.67	9.77	19.03	15.59
Capital Expenditures, 3 Yr. CAGR %	4.9	10.13	26.56	11.28	-12.25
Levered Free Cash Flow, 3 Yr. CAGR %	3.28	-21.77	-21.81	-16.92	38.67
Unlevered Free Cash Flow, 3 Yr. CAGR %	5.39	-18.76	-18.81	-12.92	36.24
Dividend Per Share, 3 Yr. CAGR %	-	-	-	36.11	12.09
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	0.17	4.68	5.12	5.74	5.71
Gross Profit, 5 Yr. CAGR %	-1.22	8.54	8.45	8.02	8.57
EBITDA, 5 Yr. CAGR %	-5.9	9.11	6.6	4.47	11.58
EBITA, 5 Yr. CAGR %	-7.98	9.76	6.07	3.54	12.36
EBIT, 5 Yr. CAGR %	-10.49	74.3	72.94	54.38	70.48
Earnings From Cont. Operations, 5 Yr. CAGR %	11.51	17.21	5.53	33.82	9.19
Net Income, 5 Yr. CAGR %	11.51	17.21	5.53	33.82	9.19
Normalized Net Income, 5 Yr. CAGR %	-0.33	66.63	191.55	65.42	94.06
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	5.51	33.34	8.82
Accounts Receivable, 5 Yr. CAGR %	1.98	2.57	3.18	6.05	4.15
Inventory, 5 Yr. CAGR %	7.43	9.49	10.11	10.03	8.55
Net Property, Plant and Equip., 5 Yr. CAGR %	11.95	12.25	11.52	10.41	7.08
Total Assets, 5 Yr. CAGR %	-0.43	0.19	1.3	1.82	1.88
Tangible Book Value, 5 Yr. CAGR %	-3.31	4.17	-18.18	-4.42	35.14
Common Equity, 5 Yr. CAGR %	-4.45	-3.5	-3.1	-1.85	2.23
Cash From Operations, 5 Yr. CAGR %	-9.69	1.56	-0.02	4.02	17.69
Capital Expenditures, 5 Yr. CAGR %	1.44	9.53	21.99	4.72	-3.08
Levered Free Cash Flow, 5 Yr. CAGR %	-	-4.66	-14.43	-17.67	10.96
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-2.75	-11.33	-13.88	10.97